Cargando…

Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement

Granulocytic sarcoma (GS) represents a rare type of extramedullar manifestation from the acute myeloid leukaemia (AML). We report the case of a patient with recurrences of AML M4eo leukaemia in the uterus and the small intestine at 3 and 5 years, respectively, after matched related peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaenker, Stephan, Schweyer, Stefan, Hasenkamp, Justin, Truemper, Lorenz, Wulf, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420739/
https://www.ncbi.nlm.nih.gov/pubmed/22937311
http://dx.doi.org/10.1155/2011/692982
_version_ 1782240912694312960
author Zaenker, Stephan
Schweyer, Stefan
Hasenkamp, Justin
Truemper, Lorenz
Wulf, Gerald
author_facet Zaenker, Stephan
Schweyer, Stefan
Hasenkamp, Justin
Truemper, Lorenz
Wulf, Gerald
author_sort Zaenker, Stephan
collection PubMed
description Granulocytic sarcoma (GS) represents a rare type of extramedullar manifestation from the acute myeloid leukaemia (AML). We report the case of a patient with recurrences of AML M4eo leukaemia in the uterus and the small intestine at 3 and 5 years, respectively, after matched related peripheral blood stem cell transplantation (PBSCT). The patient underwent the withdrawal of immunosuppression, hysterectomy, and local irradiation at first relapse, as well as systemic chemotherapy and donor lymphocyte infusions at second recurrence, inducing a second and third complete remission, respectively. At year six after transplantation, the patient experienced disease progression by meningeosis leukaemia to which she succumbed despite intrathecal chemotherapy. Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control.
format Online
Article
Text
id pubmed-3420739
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34207392012-08-30 Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement Zaenker, Stephan Schweyer, Stefan Hasenkamp, Justin Truemper, Lorenz Wulf, Gerald Case Rep Hematol Case Report Granulocytic sarcoma (GS) represents a rare type of extramedullar manifestation from the acute myeloid leukaemia (AML). We report the case of a patient with recurrences of AML M4eo leukaemia in the uterus and the small intestine at 3 and 5 years, respectively, after matched related peripheral blood stem cell transplantation (PBSCT). The patient underwent the withdrawal of immunosuppression, hysterectomy, and local irradiation at first relapse, as well as systemic chemotherapy and donor lymphocyte infusions at second recurrence, inducing a second and third complete remission, respectively. At year six after transplantation, the patient experienced disease progression by meningeosis leukaemia to which she succumbed despite intrathecal chemotherapy. Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control. Hindawi Publishing Corporation 2011 2011-09-05 /pmc/articles/PMC3420739/ /pubmed/22937311 http://dx.doi.org/10.1155/2011/692982 Text en Copyright © 2011 Stephan Zaenker et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Zaenker, Stephan
Schweyer, Stefan
Hasenkamp, Justin
Truemper, Lorenz
Wulf, Gerald
Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
title Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
title_full Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
title_fullStr Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
title_full_unstemmed Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
title_short Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
title_sort granulocytic sarcoma by aml m4eo (inv16) after allogeneic stem cell transplantation without bone marrow involvement
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420739/
https://www.ncbi.nlm.nih.gov/pubmed/22937311
http://dx.doi.org/10.1155/2011/692982
work_keys_str_mv AT zaenkerstephan granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement
AT schweyerstefan granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement
AT hasenkampjustin granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement
AT truemperlorenz granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement
AT wulfgerald granulocyticsarcomabyamlm4eoinv16afterallogeneicstemcelltransplantationwithoutbonemarrowinvolvement